Myocardial scintigraphy / PET

Myocardial perfusion scintigraphy (single photon emission computed tomography, SPECT) and positron emission tomography (PET) are suitable for detecting myocardial circulatory disorders. A slightly radioactive substance (tracer) is administered at rest and under physical or medical cardiac stress.

The regional distribution of the tracer in the myocardium makes it possible to visualize ischemia or scarring of the left ventricular myocardium. In addition, the extent and exact localization of myocardial ischemia allow an optimal treatment strategy to be defined for each patient. The PET examination offers a higher resolution with lower radiation exposure than SPECT.

Cardiac MRI also makes it possible to visualize myocardial perfusion, but a contrast agent containing gadolinium is used instead of the radioactive tracer. Finally, stress echocardiography can also detect circulatory disorders indirectly through wall motion disturbances that occur under stress.

Kardiale Bildgebung mittels CT (A), Hybrid-Untersuchung (hier Kombination aus CT und PET) (B) und Herz-MRI (C) bei verschiedenen Patienten und Patientinnen.

Complementary to SPECT and PET, computed tomography (CT) coronary angiography does not provide any information on myocardial blood flow, but does show wall changes or stenoses of the coronary arteries. The spatial resolution of the coronary CT has been continuously improved (currently 0.23 mm) and the radiation exposure reduced (currently 0.6 mSv). The strength of cardiac CT lies in its negative predictive value.

SPECT

  • Advantages: Diagnostic and prognostic accuracy. Long experience. Short scanning time.
  • Disadvantages: Radiation exposure (3-9 mSv)

PET

  • Advantages: Very high diagnostic accuracy. Ischemia and microcirculatory disorder (NH3) and vitality assessment (FDG).
  • Disadvantages: Radiation exposure (2-4 mSv)

Since the end of 2014, the latest technological innovation has been available, namely an integrated PET/MR, which comprises both a PET with state-of-the-art detector technology and a 3T MRI device. In addition to its use in neurology and oncology, combined PET/MR hybrid diagnostics is also being introduced. As with PET/CT hybrid diagnostics, PET/MR allows the diagnostic significance of ischemia clarification, vitality diagnostics, cardiomyopathies and sarcoidosis to be further increased.

Responsible professionals

Philipp Kaufmann, Prof. Dr. med.

Director of Department, Department of Nuclear Medicine

Tel. +41 44 255 15 00
Specialties: Specialist for non-invasive cardiac imaging (PET, SPECT, CT, MRI), Specialist FMH for Nuclear Medicine, Cardiology and Internal Medicine

Ronny Ralf Büchel, Prof. Dr. med.

Senior Physician, Vice Director of Department, Department of Nuclear Medicine

Tel. +41 43 253 87 89
Specialties: Specialist in multimodal non-invasive cardiac imaging (PET, SPECT, CT, MRI)., FMH specialist in nuclear medicine and cardiology., Research group: Hybrid and molecular cardiac imaging

Aju Pazhenkottil, Executive MBA HSG, Prof. Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Attending Physician, Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine

Tel. +41 44 255 39 50
Specialties: Specialist in multimodal non-invasive cardiac imaging (cardiac CT, MRI, PET, SPECT, echocardiography), Specialist in cardiology FMH, Focus on psychocardiology

For patients

You can either register yourself or be referred by your primary care physician, specialist.

Tel. +41 44 255 15 15
Self-registration

For referrering physicians

University Hospital Zurich
University Heart Center Zurich
Raemistrasse 100
8091 Zurich

Tel. +41 44 255 15 15
Patient registration form

Responsible Department